| Dr Saad Ahmad, MD | |
|
3720 Katalin Ct Ste 100, Bay City, MI 48706-2125 | |
| (989) 778-1425 | |
| (866) 287-5136 |
| Full Name | Dr Saad Ahmad |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 33 Years |
| Location | 3720 Katalin Ct Ste 100, Bay City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750562153 | NPI | - | NPPES |
| 105245347 | Medicaid | MI | |
| 01009894 | Other | MI | HEALTHPLUS OF MI |
| 0091118 | Other | MI | BLUE CROSS BLUE SHIELD OF MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 4301059847 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mclaren Bay Region | Bay city, MI | Hospital |
| Mclaren Caro Region | Caro, MI | Hospital |
| Entity Name | Huron Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245257880 PECOS PAC ID: 6800709221 Enrollment ID: O20040302000921 |
News Archive
Researchers have found that within one and half hour of taking an energy drink the internal diameter of the blood vessels is reduced by half on an average. As the blood vessels narrow, the vital blood supply to the organs also reduces and this can lead to several problems – heart attacks and strokes being just two of them.
Teva Pharmaceuticals Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today the initiation of SYNERGY, a global Phase 3 trial evaluating custirsen (also known as OGX-011/TV-1011) as first line therapy for the treatment of castrate-resistant prostate cancer (CRPC).
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
Incidence rates of skin cancer (cutaneous malignant melanoma) have increased more than 550% in males and 250% in females since the early 1980s in England - according to a new study by Brighton and Sussex Medical School (BSMS).
› Verified 3 days ago
| Entity Name | Mclaren Central Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245266063 PECOS PAC ID: 6103733092 Enrollment ID: O20040309000447 |
News Archive
Researchers have found that within one and half hour of taking an energy drink the internal diameter of the blood vessels is reduced by half on an average. As the blood vessels narrow, the vital blood supply to the organs also reduces and this can lead to several problems – heart attacks and strokes being just two of them.
Teva Pharmaceuticals Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today the initiation of SYNERGY, a global Phase 3 trial evaluating custirsen (also known as OGX-011/TV-1011) as first line therapy for the treatment of castrate-resistant prostate cancer (CRPC).
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
Incidence rates of skin cancer (cutaneous malignant melanoma) have increased more than 550% in males and 250% in females since the early 1980s in England - according to a new study by Brighton and Sussex Medical School (BSMS).
› Verified 3 days ago
| Entity Name | Caro Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073568978 PECOS PAC ID: 9234048166 Enrollment ID: O20040327000046 |
News Archive
Researchers have found that within one and half hour of taking an energy drink the internal diameter of the blood vessels is reduced by half on an average. As the blood vessels narrow, the vital blood supply to the organs also reduces and this can lead to several problems – heart attacks and strokes being just two of them.
Teva Pharmaceuticals Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today the initiation of SYNERGY, a global Phase 3 trial evaluating custirsen (also known as OGX-011/TV-1011) as first line therapy for the treatment of castrate-resistant prostate cancer (CRPC).
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
Incidence rates of skin cancer (cutaneous malignant melanoma) have increased more than 550% in males and 250% in females since the early 1980s in England - according to a new study by Brighton and Sussex Medical School (BSMS).
› Verified 3 days ago
| Entity Name | Mymichigan Medical Center West Branch |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538566765 PECOS PAC ID: 7214251081 Enrollment ID: O20160714002424 |
News Archive
Researchers have found that within one and half hour of taking an energy drink the internal diameter of the blood vessels is reduced by half on an average. As the blood vessels narrow, the vital blood supply to the organs also reduces and this can lead to several problems – heart attacks and strokes being just two of them.
Teva Pharmaceuticals Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today the initiation of SYNERGY, a global Phase 3 trial evaluating custirsen (also known as OGX-011/TV-1011) as first line therapy for the treatment of castrate-resistant prostate cancer (CRPC).
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
Incidence rates of skin cancer (cutaneous malignant melanoma) have increased more than 550% in males and 250% in females since the early 1980s in England - according to a new study by Brighton and Sussex Medical School (BSMS).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Saad Ahmad, MD 3720 Katalin Ct Ste 100, Bay City, MI 48706-2125 Ph: (989) 778-1425 | Dr Saad Ahmad, MD 3720 Katalin Ct Ste 100, Bay City, MI 48706-2125 Ph: (989) 778-1425 |
News Archive
Researchers have found that within one and half hour of taking an energy drink the internal diameter of the blood vessels is reduced by half on an average. As the blood vessels narrow, the vital blood supply to the organs also reduces and this can lead to several problems – heart attacks and strokes being just two of them.
Teva Pharmaceuticals Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today the initiation of SYNERGY, a global Phase 3 trial evaluating custirsen (also known as OGX-011/TV-1011) as first line therapy for the treatment of castrate-resistant prostate cancer (CRPC).
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
Incidence rates of skin cancer (cutaneous malignant melanoma) have increased more than 550% in males and 250% in females since the early 1980s in England - according to a new study by Brighton and Sussex Medical School (BSMS).
› Verified 3 days ago
John A Howland, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2110 16th St, Bay City, MI 48708 Phone: 989-892-1231 Fax: 989-892-1881 | |
Krisshonda D Mckinney, FNP-C Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 3720 Katalin Ct, Bay City, MI 48706 Phone: 989-686-2800 | |
Marvin R Keeling, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1484 Straits Dr Ste 5, Bay City, MI 48706 Phone: 989-667-8740 Fax: 989-667-8745 | |
Dr. Algimantas P Maciulis, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 S. Wenona St, Suite 260, Bay City, MI 48706 Phone: 989-894-6040 Fax: 989-892-3983 | |
Dr. Lakshmi Arekapudi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3720 Katalin Ct, Bay City, MI 48706 Phone: 989-686-2800 | |
Ali Soueidan, M.D Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 S Trumbull St, Bay City, MI 48708 Phone: 989-893-7460 Fax: 989-895-5813 | |
Dr. Praveen Kumar Kamaraju, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3720 Katalin Court, Bay City, MI 48706 Phone: 989-686-2800 Fax: 989-686-5920 |